Critics say the structure of the deal provides a rich payout of $675 million in fees to the lawyers helping promote the deal, but paltry payments for the cancer sufferers who make up the class.
Justices weigh Monsanto's claim of EPA 'green light' for business as usual while Trump’s pro-glyphosate executive order clashes with MAHA’s anti-pesticide push.
